Health in Jamaica

1,268 indicators covering health for Jamaica.

IndicatorLatest Year10-yr change Rank
Prevalence of wasting, weight for height 3.2% 2018 up 28.0% 62nd
Bladder cancer death rate 1.61 2014 up 2.2% 61st
Cancer death rates by type who db 1.61 2014 up 2.2% 61st
Weight-for-height <-2 SD 3.17 2018 up 26.3% 63rd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 95.0% 2025 49th
International Health Regulations core capacity scores, SPAR version 40 2025 112th
Prevalence of underweight, weight for age 2.5% 2018 up 4.2% 83rd
Leprosy registered prevalence rate per 1 000 000 population 0.352 2024 105th
Leprosy - Number of new leprosy cases among children 0 2024 69th
Leprosy - Number of cases registered for treatment 1 2024 down 80.0% 113th
New leprosy child case detection rate (less than 15 years of age) per 0 2024 69th
Children (0-14) living with HIV 500 2024 down 28.6% 66th
Ipv1 number unvaccinated 659.5 2023 down 97.4% 153rd
Children living with hiv 500 2024 down 28.6% 66th
Contraceptive prevalence, any method 60.6% 2022 down 16.4% 48th
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 3rd
Age-standardized prevalence of current tobacco use among persons aged 11.5% 2024 down 15.4% 114th
Liver cancer death rate 2.94 2014 down 12.7% 88th
Number of female leprosy new cases 0 2024 down 100.0% 102nd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 1st
Contraceptive prevalence, any modern method 53.2% 2022 down 22.2% 44th
Number of prevalent tuberculosis cases 170 2014 down 5.6% 168th
Number of new G2D leprosy cases 0 2024 down 100.0% 86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 down 100.0% 86th
3.7.2 Adolescent birth rate per 1,000 women 36 2018 down 34.2% 89th
Proportion of total government spending on essential services, health 11.0% 2015 up 60.1% 58th
3.1.2 Proportion of births attended by skilled health personnel 100 2018 up 7.5% 1st
Pancreatic cancer death rate 3.75 2014 up 33.5% 73rd
Brain and nervous system cancer death rate 1.44 2014 down 5.4% 93rd
Inflation-adjusted prices for most sold brand of cigarettes: Prices 17.55 2022 up 17.9% 8th
Taxes as a % of price: total tax 38.8% 2022 down 15.8% 134th
Taxes as a % of price: value added tax 13.0% 2022 down 7.9% 84th
Taxes as a % of price: ad valorem excise 0.0% 2022 106th
Taxes as a % of price: specific excise 24.3% 2022 down 23.7% 93rd
Taxes as a % of price: import duties 0.0% 2022 38th
Taxes as a % of price: other taxes 1.4% 2022 up 1,687.5% 33rd
Inflation-adjusted prices for most sold brand of cigarettes: Price in 1,400 2022 up 23.0% 24th
Estimated number of children needing antiretroviral therapy based on 500 2025 down 31.5% 64th
Weight-for-height <-3 SD 0.9919 2018 up 263.6% 45th
Prevalence of severe wasting, weight for height 1.0% 2018 up 233.3% 43rd
Physical activity policies for activie societies 10 2023 unchanged 113th
Physical activity policies focused on active systems 10 2023 unchanged 101st
Midwifery personnel 550 2024 up 78.6% 99th
Estimated antiretroviral therapy coverage among children 48 2025 up 20.0% 48th
Child population under age 5 160.7 2025 down 16.6% 21st
Percentage of children as a proportion of total population 22.77 2025 down 21.5% 22nd
Child population 10-19 405.65 2025 down 20.6% 21st
Death rate from poisonings 0.1 2021 unchanged 158th
3.8.1 Coverage of essential health services 74 2021 up 12.1% 78th
Mortality rate attributed to cardiovascular disease, cancer, diabetes 20.2 2021 up 38.4% 72nd
Mortality rate attributed to unintentional poisonings, by sex 0.1 2021 unchanged 143rd
Suicide mortality rate, by sex 1.7 2021 up 70.0% 155th
Share of deaths registered 100 2019 1st
Prevalence of stunting, height for age 4.6% 2018 down 33.3% 90th
Affordability - percentage of GDP per capita required to purchase 14.67 2022 up 7.8% 20th
Child population 645.96 2025 down 20.5% 21st
Deaths and missing persons due to natural disasters 0 2023 down 100.0% 117th
Mean systolic blood pressure 126.2 2009 up 1.4% 88th
Mean fasting blood glucose (mmol/l) 5.8 2009 up 7.4% 15th
Number of pregnant women living with HIV who received antiretrovirals 288 2025 down 30.4% 55th